Rockville, United States
Advasur is a health care and pharmaceutical startup founded in 2003 that offers a comprehensive suite of 10 Drug Quality Security Act (DQSA) Serialization Compliance Services. The company's slogan, "Advasur offers a comprehensive suite of 10 Drug Quality Security Act (DQSA) Serialization Compliance Services," defines its core offering.
Their flagship product, Advasur-Rx Serialization Compliance Services (SCS), aims to remove the direct burden of track and trace compliance for Advasur’s dispenser clients, ensuring improved business processes and comprehensive data collection and product traceability services. The solution addresses the impact of serialization compliance requirements on all 3 trading partners, thereby preventing cost shifts from manufacturers and wholesalers to dispensers.
Despite being a key player in the industry, there is no information available regarding their headquarter, last investment, or the investors involved in their last investment.
Overall, Advasur's focus on resolving compliance challenges in the pharmaceutical sector, as well as their commitment to preventing cost shifts for their clients, positions them as a notable player in the industry. With increasing regulatory requirements, Advasur's services are likely to be in high demand, making them an attractive investment opportunity for venture capital firms looking to tap into the health care and pharmaceutical industries.
